SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-038039
Filing Date
2019-08-07
Accepted
2019-08-07 08:00:32
Documents
3
Period of Report
2019-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv526961_8k.htm 8-K 21441
2 EXHIBIT 99.1 tv526961_ex99-1.htm EX-99.1 69292
3 GRAPHIC image_001.jpg GRAPHIC 4749
  Complete submission text file 0001144204-19-038039.txt   98821
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 191003869
SIC: 8731 Services-Commercial Physical & Biological Research